NYSE:BMY
Bristol Myers Squibb Co.
Bristol Myers Squibb Co.'s revenue fell 0.2% in fiscal 2025 to $48.2B. Free cash flow was $12.8B, 26.7% of revenue, and the diluted share count rose 0.6%.Summary generated from Bristol Myers Squibb Co.'s SEC filings. Latest annual report filed Feb 11, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$48.2B
Revenue growth−0.2%
Revenue, 5-yr CAGR+2.5%
Gross margin71.1%
Operating marginn/a
Net margin14.6%
ROICn/a
Return on equity40.5%
Debt / equity2.55
Free cash flow$12.8B
FCF margin26.7%
Share count change+0.6%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 46.4 | 46.2 | 45.0 | 48.3 | 48.2 |
| Operating income | n/a | n/a | n/a | n/a | n/a |
| Net income | 7.0 | 6.3 | 8.0 | −8.9 | 7.1 |
| Free cash flow | 15.2 | 11.9 | 12.7 | 13.9 | 12.8 |
Recent filings
- 4Insider transaction report
Oct 5, 2026 - 4Insider transaction report
Oct 2, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 30, 2026 - 8-KResults of operations and financial condition
Jul 30, 2026 - 8-KResults of a shareholder vote
May 8, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
Apr 30, 2026 - 8-KResults of operations and financial condition
Apr 30, 2026 - DEF 14AProxy statement
Mar 25, 2026